Quantcast
Last updated on April 24, 2014 at 16:36 EDT

Latest ExAblate Stories

2012-02-11 05:00:00

LIVERMORE, Calif., Feb. 11, 2012 /PRNewswire/ -- Halt Medical, Inc. announced today that it has closed on the first $20 million of a planned $50 million debt and equity financing. "Leading the financing with the first $20 million is our long term investment partner American Capital Strategies (ACAS). American Capital's financial resources, global perspective and life science expertise has made them the perfect financing partner for Halt Medical. Following the lead of American Capital,...

2012-01-24 03:00:00

TIRAT CARMEL, Israel, January 24, 2012 /PRNewswire/ -- InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced that it has submitted a premarket approval application (PMA) to the U.S. Food and Drug Administration (FDA) for its ExAblate treatment of pain palliation of bone metastases. [http://www.bone-pain-palliation.co.uk ] ExAblate uses MR guided focused ultrasound (MRgFUS) to treat the pain caused by bone metastases non-invasively and without ionizing...

2012-01-03 03:30:00

TIRAT CARMEL, Israel, January 3, 2012 /PRNewswire/ -- InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS) therapy, announced today that it has completed enrollment in the world's first feasibility study [http://www.clinicaltrials.gov/ct2/show/NCT01304758?term=ExAblate&rank=4 ] evaluating the use of MRgFUS for treatment of Essential [http://www.insightec.com/Essential_Tremor.html ] Tremor, using ExAblate(R) Neuro at University of Virginia...

2011-11-27 03:00:00

TIRAT CARMEL, Israel, November 27, 2011 /PRNewswire/ -- InSightec Ltd announced that NICE, the National Institute for Health and Clinical Excellence of the NHS in the UK, announced new favorable guidelines for the treatment of uterine fibroids using MR guided Focused Ultrasound. The new guidelines state that the current evidence on the efficacy of magnetic resonance image (MRI)-guided transcutaneous focused ultrasound treatment for uterine fibroids and evidence on safety are...

2011-10-03 14:00:00

Results of first-in-world study could open doors to treating other brain disorders WASHINGTON, Oct. 3, 2011 /PRNewswire-USNewswire/ -- In a presentation at the Congress of Neurological Surgeons today, University of Virginia neurosurgeon W. Jeffrey Elias, MD reported that preliminary results of a pilot clinical trial indicate that MR-guided focused ultrasound has the potential to safely and effectively control essential tremor (ET), a common neurological condition that affects 10 million...

2011-09-21 02:00:00

TIRAT CARMEL, Israel, September 21, 2011 /PRNewswire/ -- InSightec Ltd., the global leader in MR guided Focused Ultrasound (MRgFUS) technology, announced today that its investigational ExAblate(R) Neuro system has been used in clinical studies to treat 30 patients suffering from chronic neurological disorders. The clinical trials are being conducted by functional neurosurgeons, neurologists and neuroradiologists in Switzerland, and the US to evaluate the safety and initial...

2011-07-13 08:00:00

TIRAT CARMEL, Israel, July 13, 2011 /PRNewswire/ -- Initial Results are Encouraging, Spurring Hope for a Treatment Option With a Lower Rate of Complications InSightec Ltd., the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that 23 patients with organ confined low risk prostate cancer have already been treated with its ExAblate(R) system in...

2011-06-22 11:12:00

CHARLOTTESVILLE, Va., June 22, 2011 /PRNewswire/ -- On June 12, 2011, viewers of the CBS Evening News learned about Stephanie Small's gripping story. Suffering from a large uterine fibroid, the 27-year-old was treated last December as part of a MR-guided focused ultrasound clinical trial at the University of Virginia in Charlottesville. Small says her focused ultrasound treatment changed her life. She experienced symptom relief within a few days and reports that her quality of life has...

2011-03-09 10:21:00

Noninvasive, deep brain therapy could benefit patients worldwide CHARLOTTESVILLE, Va., March 9, 2011 /PRNewswire-USNewswire/ -- A new chapter in medical history opened days ago when noninvasive MR-guided focused ultrasound was used to successfully treat a patient with essential tremor (ET), a progressive neurological disorder that affects millions of people worldwide and causes involuntary shaking of the hands, head, face, eyelids, voice or other muscles. The procedure has been...

2011-03-01 12:55:18

Women who received one of three treatments for uterine fibroids at Brigham and Women's Hospital in Boston said their symptoms diminished and their quality of life significantly increased, according to a new study published in the May issue of Radiology. Uterine fibroids are benign pelvic tumors that occur in as many as one in five women during their childbearing years. Although not all fibroids cause symptoms, some women experience heavy bleeding, pain and infertility. Treatment options...